Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites

World Journal of Gastroenterology

Volumn 14, Issue 24, 2008, Pages 3884-3890

  Lee, Soong ^b   Son, Seung Cheol ^b   Han, Moon Jong ^b   Kim, Woo Jin ^b   Kim, Soo Hyun ^a   Kim, Hye Ran ^a   Jeon, Woo Kyu ^c   Park, Ki Hong ^d   Shin, Myung Geun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Seonam University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Korea Polymert Testing and Research Institute Ltd   (South Korea)

Author keywords

Ascites; Intestinal permeability; Liver cirrhosis; Nitric oxide; Tumor necrosis factor

Indexed keywords

MACROGOL 3350; MACROGOL 400; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASCITES; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA PERMEABILITY; LIVER CIRRHOSIS; MACROMOLECULE; MAJOR CLINICAL STUDY; MALE; NITROGEN URINE LEVEL; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

EID: 54349086880     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3884     Document Type: Article

References (35)

1. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-1581
2. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002; 34: 385-396
3. Budillon G, Parrilli G, Pacella M, Cuomo R, Menzies IS. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1985; 1: 513-524
4. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003; 18: 479-497
5. Kalaitzakis E, Johansson JE, Bjarnason I, Bjornsson E. Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 2006; 41: 326-330
6. Fujii T, Seki T, Maruoka M, Tanaka J, Kawashima Y, Watanabe T, Sawamura T, Inoue K. Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis. Hepatol Res 2001; 19: 158-169
7. Huglo D, De Botton S, Canva-Delcambre V, Colombel JF, Wallaert B, Steinling M, Marchandise X. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med 2001; 28: 1505-1511
8. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11: 755-759
9. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, Girona E, Gutierrez A, Carnices F, Palazon JM, Sola-Vera J, Perez-Mateo M. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50: 1482-1486
10. Zuckerman MJ, Menzies IS, Ho H, Gregory GG, Casner NA, Crane RS, Hernandez JA. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 2004; 49: 621-626
11. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486
12. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1998; 123: 1459-1464
13. Odeh M, Sabo E, Srugo I, Oliven A. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int 2004; 24: 110-116
14. Kiki I, Yilmaz O, Erdem F, Gundogdu M, Demircan B, Bilici M. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores. Int J Clin Pract 2006; 60: 1075-1079
15. Zhang W, Yue B, Wang GQ, Lu SL. Serum and ascites levels of macrophage migration inhibitory factor, INF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 2002; 1: 577-580
16. Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, Macias MA, Rendon P, Diaz F, Fernandez-Gutierrez C, Martin-Herrera L. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004; 24: 437-445
17. Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, Liao TM, Lin LF, Wang SS, Lee SD. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scand J Gastroenterol 1996; 31: 500-505
18. Eriksson AS, Gretzer C, Wallerstedt S. Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis. Hepatogastroenterology 2004; 51: 505-509
19. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-778
20. Oudenhoven IM, Klaasen HL, Lapre JA, Weerkamp AH, Van der Meer R. Nitric oxide-derived urinary nitrate as a marker of intestinal bacterial translocation in rats. Gastroenterology 1994; 107: 47-53
21. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002; 34: 385-396
22. Rahman SH, Ammori BJ, Larvin M, McMahon MJ. Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response? Gut 2003; 52: 270-274.
23. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999; 94: 200-207
24. McKay DM, Baird AW. Cytokine regulation of epithelial permeability and ion transport. Gut 1999; 44: 283-289
25. Wallace JL, Miller MJ. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000; 119: 512-520
26. Banan A, Fields JZ, Zhang Y, Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1234-G1246
27. Philipsen EK, Batsberg W, Christensen AB. Gastrointestinal permeability to polyethylene glycol: an evaluation of urinary recovery of an oral load of polyethylene glycol as a parameter of intestinal permeability in man. Eur J Clin Invest 1988; 18: 139-145
28. Parlesak A, Bode JC, Bode C. Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol. Eur J Clin Chem Clin Biochem 1994; 32: 813-820
29. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000; 32: 742-747
30. Loret S, Nollevaux G, Remacle R, Klimek M, Barakat I, Deloyer P, Grandfils C, Dandrifosse G. Analysis of PEG 400 and 4000 in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography, with refractometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 805: 195-202
31. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Mourelle M, Moncada S. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139-1143
32. Elsing C, Harenberg S, Stremmel W, Herrmann T. Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol 2007; 13: 421-425
33. Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, Martinez M, Lopez-Talavera JC, Esteban R, Groszmann RJ, Guardia J. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis: Am J Gastroenterol 1999; 94: 169-177
34. Barsacchi R, Perrotta C, Bulotta S, Moncada S, Borgese N, Clementi E. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3' kinase, and Akt. Mol Pharmacol 2003; 63: 886-895
35. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104: 1223-1233